Login
| TI Ref No : | 508482977 |
|---|---|
| Description : | Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Golimumab (l04ab06) Within The Framework Of A So-called Open House Model. |
| Date : | 2024-09-20 |
| Deadline : | 2026-08-31 |
| Document Type : | Tenders |
